WT1 PEPTIDE VACCINATION FOR MALIGNANT GLIOMAS AS A PART OF MULTI-MODAL THERAPY

BACKGROUND: We have been conducting clinical trials of peptide vaccination targeting WT1 gene product against malignant gliomas. Given the results of phase II trial for recurrent malignant gliomas (Izumoto, Hashimoto et al., J Neurosurg 2008), we performed recursive partitioning analyses (RPA) (Cars...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hashimoto, Naoya, Tsuboi, Akihiro, Chiba, Yasuyoshi, Hirayama, Ryuichi, Takano, Koji, Kijima, Noriyuki, Oka, Yoshihiro, Kagawa, Naoki, Izumoto, Shuichi, Sugiyama, Haruo, Yoshimine, Toshiki
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144609/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou208.60
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars